print
email
   
   
Investors > Financials by Segment
Segment wise revenue, results, assets,liabilities and capital employed
for the quarter and year ended 31 March, 2017
Rs.In Lacs
  Standalone Consolidated
  Quarter Ended
Year Ended
Year Ended
  Audited
31st March
Unaudited
31st
December
Audited
31st March
Audited
31st March
Audited
31st March
Audited
31st March
Audited
31st March
  2017 2016 2016
2017
2016
2017
2016

1. Segment revenue

             

  a) Pharmaceuticals

17,638 14,275 16,900 60,521 56,914 60,521 56,914

  b) Crop protection products

13,318 10,809 12,079 40,873 35,651 40,873 35,651

  c) Overseas operation

- - - - - - -

Total

30,956 25,084 28,979 101,394 92,565 101,394 92,565

Less: Inter segment revenue

- - - - - -  

 Net sales / income from operation

30,956 25,084 28,979 101,394 92,565 101,394 92,565

2. Segment results

             

Profit before interest & tax

             

  a) Pharmaceuticals

2,226 1,688 2,376 7,866 8,051 7,866 8,051

  b) Crop protection products

2,570 2,056 2,455 7,545 5,472 7,545 5,472

  c) Overseas operation

- - - - - - (9)

Total

4,796 3,744 4,831 15,411 13,523 15,411 13,514

Less :

             

  i) Finance cost

914 1,444 1,327 4,877 6,218 4,878 6,221
  ii) Other un-allocable
      expenditure
730 546 617 2,391 2,072 2,260 2,072
Add :              

  i) Other un-allocable income

41 31 39 152 98 152 98

  Profit before tax

3,193 1,785 2,926 8,295 5,331 8,425 5,319
               

3. Segment assets

             

 a) Pharmaceuticals

79,408 79,939 82,179 79,408 82,179 79,408 82,179

 b) Crop protection products

40,458 37,339 31,715 40,458 31,715 40,458 31,715

 c) Overseas operation

- - - - - - -

 d) Unallocated

13,836 14,228 13,716 13,836 13,716 13,835 13,610

Total segment assets

133,702 131,506 127,610 133,702 127,610 133,701 127,504
               

4. Segment liabilities

             

 a) Pharmaceuticals

9,102 8,699 9,840 9,102 9,840 9,102 9,840

 b) Crop protection products

6,964 6,034 4,766 6,964 4,766 6,964 4,766

 c) Overseas operation

- - - - - - -

 d) Unallocated

56,103 56,797 56,514 56,103 56,514 56,103 56,519

Total segment liabilities

72,169 71,530 71,120 72,169 71,120 72,169 71,125
               

5. Capital employed

             

 a) Pharmaceuticals

70,306 71,240 72,339 70,306 72,339 70,306 72,339

 b) Crop protection products

33,494 31,305 26,949 33,494 26,949 33,494 26,949

 c) Overseas operation

- - - - - - -

 d) Unallocated

(42,267) (42,569) (42,798) (42,267) (42,798) (42,267) (42,909)

Total capital employed

61,533 59,976 56,490 61,533 56,490 61,532 56,379